Evaluation of the Potential Role of Alirocumab in the Management of Hypercholesterolemia in Patients with High‐Risk Cardiovascular Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1875-9114|35|8|771-779

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.35, Iss.8, 2015-08, pp. : 771-779

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The emerging role of carotid artery stenting in the management of high-risk patients with carotid artery disease

By Dieter Robert S   Schmidt Wade T   Pacanowski Jr John P  

Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. : 175-176

Future Medicine

Access to resources Recommend Favorite

Simultaneous Detection of Multiple Familial Hypercholesterolemia Mutations Facilitates an Improved Diagnostic Service in South African Patients at High Risk of Cardiovascular Disease

By Kotze M.J.   Kriegshäuser G.  

Molecular Diagnosis, Vol. 7, Iss. 3, 2003-01 ,pp. : 169-174

Adis International

Access to resources Recommend Favorite

Telmisartan for the management of patients at high cardiovascular risk

By Ruilope Luis M.  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1673-1682

Informa Healthcare

Access to resources Recommend Favorite

Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease

By Ferdinand Keith C.  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 1091-1098

Informa Healthcare

Access to resources Recommend Favorite

Glycemic control and cardiovascular disease in a high-risk chronic kidney disease population

By Singh Rachandeep   Nistala Ravi   McFarlane Samy I   Whaley-Connell Adam  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 507-513

Future Medicine

Access to resources Recommend Favorite